Article Text

PDF
Research paper
Familial gain-of-function Nav1.9 mutation in a painful channelopathy
  1. Chongyang Han1,2,3,
  2. Yang Yang1,2,3,
  3. Rene H te Morsche4,
  4. Joost P H Drenth4,
  5. Juan M Politei5,
  6. Stephen G Waxman1,2,3,
  7. Sulayman D Dib-Hajj1,2,3
  1. 1Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA
  2. 2Center for Neuroscience and Regeneration Research, Yale University School of Medicine, New Haven, Connecticut, USA
  3. 3Center for Restoration of Nervous System Function, Veterans Affairs Medical Center, West Haven, Connecticut, USA
  4. 4Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  5. 5Department of Neurology, Fundación para el Estudio de las Enfermedades Neurometabólicas, Buenos Aires, Argentina
  1. Correspondence to Dr Sulayman D Dib-Hajj, Department of Neurology, Neuroscience Research Center, Yale University School of Medicine, Bldg 34, VA Connecticut Healthcare System (127A), 950 Campbell Avenue, West Haven, CT 06516, USA; Sulayman.dib-hajj{at}yale.edu

Abstract

Objective Gain-of-function mutations in Nav1.9 have been identified in three families with rare heritable pain disorders, and in patients with painful small-fibre neuropathy. Identification and functional assessment of new Nav1.9 mutations will help to elucidate the phenotypic spectrum of Nav1.9 channelopathies.

Methods Patients from a large family with early-onset pain symptoms were evaluated by clinical examination and genomic screening for mutations in SCN9A and SCN11A. Electrophysiological recordings and multistate modelling analysis were implemented for functional analyses.

Results A novel Nav1.9 mutation, p.Arg222His, was identified in patients with early-onset pain in distal extremities including joints and gastrointestinal disturbances, but was absent from an asymptomatic blood relative. This mutation alters channel structure by substituting the highly conserved first arginine residue in transmembrane segment 4 (domain 1), the voltage sensor, with histidine. Voltage-clamp recordings demonstrate a hyperpolarising shift and acceleration of activation of the p.Arg222His mutant channel, which make it easier to open the channel. When expressed in dorsal root ganglion neurons, mutant p.Arg222His channels increase excitability via a depolarisation of resting potential and increased evoked firing.

Conclusions This study expands the spectrum of heritable pain disorders linked to gain-of-function mutations in Nav1.9, strengthening human validation of this channel as a potential therapeutic target for pain.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles